Organon (OGN) Net Cash Flow (2020 - 2026)

Organon (OGN) recorded quarterly Net Cash Flow of $573.0 million in Q1 2026, up 616.22% quarter-over-quarter from -$111.0 million in Q4 2025, and up 433.14% on a YoY basis from $107.5 million in Q1 2025.

Organon (OGN) Net Cash Flow (2020 - 2026) Analysis & Trends

Organon's Net Cash Flow history runs 7 years deep, the most recent figure standing at $573.0 million for Q1 2026.

  • In Q1 2026, Net Cash Flow rose 433.14% year-over-year to $573.0 million; the TTM figure through Mar 2026 stood at $494.0 million (up 2570.0% YoY), while the FY2025 annual figure was -$251.0 million, down 532.76% from the prior year.
  • Net Cash Flow was $573.0 million for Q1 2026 at Organon, up from -$111.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $573.0 million in Q1 2026 to a low of -$266.0 million in Q1 2023.
  • Historically, Net Cash Flow has averaged $20.9 million across 5 years, with a median of -$12.0 million in 2024.
  • Biggest YoY gain for Net Cash Flow was 708.33% in 2025; the steepest drop was 1025.0% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $124.0 million in 2022, then soared by 92.74% to $239.0 million in 2023, then plunged by 94.98% to $12.0 million in 2024, then slumped by 1025.0% to -$111.0 million in 2025, then jumped by 616.22% to $573.0 million in 2026.
  • The last three Net Cash Flow figures came in at $573.0 million (Q1 2026), -$111.0 million (Q4 2025), and $73.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 210.32 Mn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -2.05 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 2.00 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 4.17 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -9.27 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 75.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 544.00 Mn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -587.00 Mn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 573.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 573.00 Mn
Mar 31, 2026 573.00 Mn
Dec 31, 2025 -111.00 Mn
Dec 31, 2025 -111.00 Mn
Sep 30, 2025 73.00 Mn
Sep 30, 2025 73.00 Mn
Jun 30, 2025 -41.00 Mn
Jun 30, 2025 -41.00 Mn
Mar 31, 2025 -172.00 Mn
Mar 31, 2025 -172.00 Mn
Dec 31, 2024 12.00 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 -12.00 Mn
Sep 30, 2024 -12.00 Mn
Jun 30, 2024 152.00 Mn
Jun 30, 2024 152.00 Mn
Mar 31, 2024 -94.00 Mn
Mar 31, 2024 -94.00 Mn
Dec 31, 2023 239.00 Mn
Dec 31, 2023 239.00 Mn